Navigation Links
Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
Date:9/6/2007

PHILADELPHIA, Sept. 6, 2007 /PRNewswire-FirstCall/ -- CIGNA Group Insurance today announced that Allen Woolf, M.D. has been appointed as chief medical officer. Woolf will have responsibility for managing the clinical aspects of the company's programs that help promote health and wellness, absence management and productivity.

In this role, Dr. Woolf will work with clinical and business leaders for CIGNA Group Insurance's disability, life and accident products and services and Intracorp's workers' compensation programs. As the leader of the company's clinical community, Dr. Woolf will collaborate closely with the physicians, nurses, vocational rehabilitation specialists and other clinical staff who manage CIGNA programs that help people return to work quickly and safely.

"Allen possesses extensive knowledge of the disability and group health industries, which positions him well for this clinical leadership role," said Karen Rohan, president of CIGNA Group Insurance and CIGNA Dental. "In addition, Allen's wealth of experience will contribute significantly to furthering CIGNA's overall goal of improving the health, well-being and security of the individuals we serve."

Dr. Woolf most recently served as the medical officer for CIGNA Behavioral Health/CareAllies. During his 23-year career with CIGNA, Woolf has been extensively involved in the creation and ongoing management of population health improvement programs. He has also held medical leadership positions with CIGNA HealthCare, Intracorp and CareAllies. A graduate of Harvard University School of Medicine, Woolf is board-certified in Pediatrics and is licensed in the states of Pennsylvania, Missouri, Arizona and Connecticut.

Woolf is a member of the Health Management Strategic Advisory Council of The Institute for Health and Productivity Management, a member of the Health Industry Forum and a Fellow of the American Academy of Pediatrics. He recently completed service as a member of the B
'/>"/>

SOURCE CIGNA Group Insurance
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Dr Reddy’s Laboratories to challenge patents on drug
2. Finding relief from Excruciating Headaches a challenge
3. ‘Never Say Die’ Spirit of Visually Challenged - Makes Him a Role Modl
4. Momentum of Stem cell research impeded by legal challenges
5. Australia Ready to Meet the Challenges of Bird Flu
6. OpenMED Nominated For Stockholm Challenge 2006 Award
7. Sexual Health Service Is Under Pressure and Faced With Financial Challenges
8. Treating Bad Breath Yet A Challenge
9. Sexy Images and Lingerie Challenge A Man’s Decision Making Skill
10. Distressed Couple Assists Parents Of Mentally Challenged Kids
11. Abuja Challenges the Government
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...ains financial implications of SSDI benefits, onli...ple with disabilities. , ...ng how to move forward after a diagnosis of a long...portant that individuals do as much as they can to... http://www.allsup.com/ [Allsup], which represent...
(Date:8/28/2008)...ntia led to daytime tiredness, symptoms of depress...s) -- Older adults who live with and provide direc...have significantly worse sleep than other older ad...ed 31 caregivers and 102 noncaregivers, ages 60 to...ght than non-caregivers and took about 10 minutes ...
(Date:8/28/2008)...RNewswire/ -- The 2008 European,Hemodialysis Emerg...ense,Medical in recognition of its pioneering Reds...sense detects the loss of blood during hemodialysi...device consists of an alarm and a sensor patch. Th...ic technology that sends signals,alerting caregive...
(Date:8/28/2008)...Northeast region with more hires,planned throughou..., Aug. 28 /PRNewswire-USNewswire/ -- The Pennsylva...afety Liaison for the,Northeast region to help hea... Patient Safety Reporting System (PA-PSRS) improve... year in focus groups with Pennsylvania Patient Sa...
Breaking Medicine News(10 mins):Health News:Social Security Disability Can Be Key to Financial Future 2Health News:Social Security Disability Can Be Key to Financial Future 3Health News:Social Security Disability Can Be Key to Financial Future 4Health News:Social Security Disability Can Be Key to Financial Future 5Health News:Social Security Disability Can Be Key to Financial Future 6Health News:Older Caregivers Prone to Worse Sleep Patterns 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 2Health News:Frost & Sullivan Honours Redsense Medical With the 2008 European Hemodialysis Emerging Company of the Year Award 3Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 2Health News:Pennsylvania Patient Safety Authority Hires Patient Safety Liaison to Help Healthcare Facilities Implement Guidance 3
...ce of the deadly bird flu infection has been confi...opean Union. Reassurance steps have been initiated...on in dead swans, last week . // The EU confirmed...boratory in Britain after a first analysis by loca...
...e Day warning has been issued by Singapore cardiol...is likely to increase risk of heart attack in othe... National University Hospital (NUH) in Singapore, ...red to confirm what men have long suspected - that...
...vers of coffee, it as been found in a study that d...e catch is that consumption should be moderate. It... type-2 diabetes in younger and middle-aged women....inked drinking more than two cups of coffee or tea...
... scientists are of the opinion that older adults w...nd heart disease. // The researchers at the Unive... high risk than those without asthma to suffer chr...abetes, arthritis, osteoporosis, stroke, and canc...
Other Medicine News:
(Date:8/27/2008).../-, - Oralair(R) Grasses 3...odynamic Study Conducted in an Allergen Challenge ...ositive results of a new study,conducted in an All...air(R) Grasses included 86 adult patients exposed ... durations: 1 week, 1 month,2 and 4 months withou...
(Date:8/27/2008)...m BLISS-52 trial, expected by mid-2009 - - Data f...ll 2009 -, ROCKVILLE, Md., Aug. 27 /PRNewswire-Fi...HGSI ) today announced it has completed enrollment... pivotal Phase 3,randomized clinical trials of Lym...ystemic lupus erythematosus (SLE). Belimumab is be...
(Date:8/26/2008)...a from landmark SYNTAX clinical trial, NATICK, Ma...ntific,Corporation (NYSE: BSX ) today announced t...s announcements at the European Society of Cardiol...ptember 3 in Munich, Germany., The Company plans ...hich compares percutaneous coronary intervention (...
(Date:8/26/2008)...ewswire/ -- Semafore Pharmaceuticals Inc.,presente...rgeted Therapies,in Cancer in Washington, D.C., an...ase inhibitors that demonstrate significant antica...d proprietary molecular scaffold has been develope...sign of pan-PI3 kinase inhibitors,as well as isofo...
Breaking Medicine Technology:Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 2Stallergenes: New Study VO 56 Highly Positive Results Conducted in an Allergen Challenge Chamber 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 2Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 3Boston Scientific Announces Schedule for European Society of Cardiology Congress 2008 4Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 2Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors 3Raydiance collaborates with Rutgers MTF to develop innovative tissue processing approaches 1269 1Raydiance collaborates with Rutgers MTF to develop innovative tissue processing approaches 1269 2Novo Nordisk Inc Announces Exclusive Agreement With Sciele Pharma Inc to Market Prandin 28R 29 1850 1Novo Nordisk Inc Announces Exclusive Agreement With Sciele Pharma Inc to Market Prandin 28R 29 1850 2Novo Nordisk Inc Announces Exclusive Agreement With Sciele Pharma Inc to Market Prandin 28R 29 1850 3Eating disorders in adolescents 6616 1Eating disorders in adolescents 6616 2Eating disorders in adolescents 6616 3Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 1Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 2Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 3Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 4Amarin Announces Completion of Comprehensive Data Analysis From Phase III Huntingtons Disease Program 6611 5
...26, 2007 - Study results show,that elevated lipopr...diovascular-specific inflammatory enzyme associate...ck and stroke, is,especially predictive of heart d...e--a serious medical condition that affects nearly...sented yesterday,at the American College of Cardio...
...wswire/ -- Cleveland Clinic,researchers today repo... density lipoprotein cholesterol (HDL) or the "goo...progression of,plaque buildup in the coronary arte...en Nissen, M.D., Chairman of Cardiovascular Medici...is clinical trial, will,present the study on Monda...
Other Medicine Technology:Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 2Study Presented at the ACC Shows Inflammatory Enzyme Lp-PLA2,Predicts Heart Disease Risk in Metabolic Syndrome Patients 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 2Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 3Cholesterol Drug Fails to Slow Progression of Coronary Disease,Cleveland Clinic Study Reports 4
The ENDO MINI-RETRACT™ 5 mm instrument has application in a variety of gynecologic, abdominal, urologic, thoracic and endoscopic procedures for temporary retraction of tissue and small tubular
...NDO PADDLE RETRACT™ 12 mm instrument has app...logic,thoracic, colorectal and other endoscopic pr... the bowel, stomach, or liver. , ,The ENDO PADDLE...tractor at the distal end of the instrument and is...
The Featured Products are kept in stock at Mediflex and are offered as 1-piece or modular in regular or extra long lengths. All come equipped with insulation, flush ports, rotating shafts, ratchets (
...ffering of single-use instruments on the market., ...engths for Bariatric Surgery. , Dual action tips ...vers the pivot points to reduce the chance of alte... eliminates gapping at connection and the need for...
Medicine Products: